Table 1 Summarize of results
From: Challenge of gastro-intestinal stromal tumor management in low-income countries: example of Benin
Patients | Age (years) | Sex | Location | Tumor stage | Histology | Immuno-histo-Chemistry | Risk of recurrence | Surgery | Targeted therapy | Survival (months) | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
N°1 | 72 | M | Colon and rectum | Metastatic | Fusiform | KIT+, DOG1+, CD34+ | High | No | Palliative | 12 | Alive |
N°2 | 40 | M | Stomach | Locally advanced | Fusiform | KIT+ | High | No | Neoadjuvant | 9 | Waiting for surgery |
N°3 | 68 | M | Stomach | Locally advanced | Fusiform | KIT+, DOG1 | High | No | Neoadjuvant | 6 | Waiting for surgery |
N°4 | 82 | F | Mesentery | Localized | Fusiform | KIT+, DOG1+ | High | Yes | Palliative (after recurrence) | 36 | Recurrence after 3 years |
N°5 | 66 | F | Stomach | Locally advanced | Mixed | KIT+, DOG1+ | High | Yes | Adjuvant | 35 | Alive |
N°6 | 52 | M | Rectum | Localized | Fusiform | KIT+ | High | Yes | Palliative (after recurrence) | 36 | Recurrence after 3 years |
N°7 | 39 | F | Jejunum | Localized | Fusiform | KIT+, DOG1+ | Low | Yes | No | 5 | Alive |
N°8 | 66 | M | Stomach | Locally advanced | Epithelioid | KIT+, DOG1+, CD34+ | High | Yes | Adjuvant | 24 | Alive |
N°9 | 43 | M | Omentum | Locally advanced | Fusiform | KIT+ | High | Yes | Adjuvant | 3 | Alive |
N°10 | 46 | M | Rectum | Locally advanced | Fusiform | KIT+, DOG1+ | High | No | Neoadjuvant | 12 | Waiting for surgery |
N°11 | 41 | M | Stomach | Locally advanced | Fusiform | KIT+ | High | No | Neoadjuvant | 7 | Waiting for surgery |
N°12 | 52 | M | Stomach | Localized | Fusiform | KIT−, DOG1− | Very low | Yes | No | 31 | Alive |
N°13 | 50 | F | Stomach | Metastatic | Fusiform | KIT+, CD34+ | High | No | Palliative | 24 | Dead |
N°14 | 62 | F | Jejunum | Locally advanced | Fusiform | KIT+, CD34+ | High | Yes | Adjuvant | 36 | Alive |
N°15 | 45 | M | Stomach | Localized | Fusiform | KIT+, CD34+ | Intermediary | Yes | No | 108 | Alive |